United Therapeutics reported $800M in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Amarin AMRN:US $ 0M 0M
Baxter International BAX:US $ 16278M 487M
Bayer BAYN:GR € 38061M 1413M
Biogen BIIB:US $ 6277.4M 1.7M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Emergent Biosolutions EBS:US $ 793.6M 7.9M
Esperion Therapeutics ESPR:US $ 259.08M 402K
GlaxoSmithKline GSK:LN 1878400M 1044200M
Halozyme Therapeutics HALO:US $ 1147.13M 359.03M
Insmed INSM:US $ 807.11M 447K
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
Intra Cellular Therapies ITCI:US $ 0M 0M
IONIS PHARMACEUT IONS:US $ 1248.4M 0.47M
Moderna Inc MRNA:US $ 641M 5M
Omeros OMER:US $ 314.36M 454K
Ptc Therapeutics PTCT:US $ 981.44M 5.79M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Seattle Genetics SGEN:US $ 0M 0M
Teva Pharmaceutical TEVA:IT 20.36B 477M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M